Minkyu Jung

3.5k total citations
140 papers, 2.1k citations indexed

About

Minkyu Jung is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Minkyu Jung has authored 140 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Oncology, 68 papers in Pulmonary and Respiratory Medicine and 26 papers in Surgery. Recurrent topics in Minkyu Jung's work include Gastric Cancer Management and Outcomes (47 papers), Colorectal Cancer Treatments and Studies (36 papers) and HER2/EGFR in Cancer Research (14 papers). Minkyu Jung is often cited by papers focused on Gastric Cancer Management and Outcomes (47 papers), Colorectal Cancer Treatments and Studies (36 papers) and HER2/EGFR in Cancer Research (14 papers). Minkyu Jung collaborates with scholars based in South Korea, United States and China. Minkyu Jung's co-authors include Sun Young Rha, Hyun Cheol Chung, Hyo Song Kim, Sang Joon Shin, Joong Bae Ahn, Seung‐Hoon Beom, Sung Hoon Noh, Su Jin Heo, Choong‐kun Lee and Jae‐Ho Cheong and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Minkyu Jung

131 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minkyu Jung South Korea 26 1.2k 886 473 454 256 140 2.1k
Masayoshi Nakanishi Japan 26 895 0.8× 1.0k 1.1× 552 1.2× 851 1.9× 185 0.7× 198 2.4k
Zhi Peng China 26 1.3k 1.1× 669 0.8× 481 1.0× 434 1.0× 201 0.8× 106 2.1k
Henk H. Hartgrink Netherlands 26 632 0.5× 1.2k 1.3× 466 1.0× 791 1.7× 171 0.7× 60 2.3k
Su‐Jin Shin South Korea 23 947 0.8× 852 1.0× 461 1.0× 392 0.9× 304 1.2× 153 2.2k
Taito Esaki Japan 29 2.1k 1.8× 1.4k 1.6× 743 1.6× 581 1.3× 353 1.4× 184 3.3k
Naoki Muguruma Japan 23 544 0.5× 687 0.8× 469 1.0× 635 1.4× 213 0.8× 161 1.9k
Hideo Baba Japan 26 1.0k 0.8× 657 0.7× 370 0.8× 712 1.6× 107 0.4× 118 2.1k
Makoto Kodaira Japan 22 855 0.7× 643 0.7× 627 1.3× 320 0.7× 234 0.9× 70 2.0k
Sun Jin Sym South Korea 25 809 0.7× 750 0.8× 230 0.5× 336 0.7× 289 1.1× 102 1.7k
Eun Sun Jung South Korea 26 660 0.6× 475 0.5× 436 0.9× 596 1.3× 144 0.6× 113 2.1k

Countries citing papers authored by Minkyu Jung

Since Specialization
Citations

This map shows the geographic impact of Minkyu Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minkyu Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minkyu Jung more than expected).

Fields of papers citing papers by Minkyu Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minkyu Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minkyu Jung. The network helps show where Minkyu Jung may publish in the future.

Co-authorship network of co-authors of Minkyu Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Minkyu Jung. A scholar is included among the top collaborators of Minkyu Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minkyu Jung. Minkyu Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seo, Junyong, Ha Uk Chung, Minkyu Jung, et al.. (2025). Development of 3D Reversible Smart Energy‐Saving Devices for Adaptive Energy Management. Advanced Materials. 37(43). e2507682–e2507682. 2 indexed citations
3.
Hwang, Soohyun, You-Hyun Kim, Soo Ick Cho, et al.. (2024). Immune phenotype profiling based on anatomic origin of melanoma and impact on clinical outcomes of immune checkpoint inhibitor treatment.. Journal of Clinical Oncology. 42(16_suppl). 9569–9569. 1 indexed citations
4.
Cho, Gyu Seok, Hyo Song Kim, Minkyu Jung, & Woo Jin Hyung. (2024). Perioperative intraperitoneal plus systemic chemotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gastric cancer: phase Ib/II single-arm prospective study. Journal of Gastrointestinal Surgery. 28(7). 1095–1103. 2 indexed citations
5.
Koo, Dong‐Hoe, Minkyu Jung, Yeul Hong Kim, et al.. (2024). Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13). Cancer Research and Treatment. 56(4). 1136–1145. 3 indexed citations
6.
Kim, Chang Gon, Minkyu Jung, Hyo Song Kim, et al.. (2023). Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer. Journal of Clinical Oncology. 41(27). 4394–4405. 27 indexed citations
7.
Kwon, Jung Hye, Seung‐Hoon Beom, Sang Joon Shin, et al.. (2023). Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea. SHILAP Revista de lepidopterología. 4(1). 9–16. 1 indexed citations
8.
Jung, Minkyu, et al.. (2023). Blank Collapse: Compressing CTC Emission for the Faster Decoding. 1349–1353. 1 indexed citations
9.
Lee, Choong‐kun, Jii Bum Lee, Se Jin Park, et al.. (2023). Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study. Gastric Cancer. 27(1). 118–130. 10 indexed citations
10.
Jung, Seung‐Hyun, Choong‐kun Lee, Woo Sun Kwon, et al.. (2023). Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy. Yonsei Medical Journal. 64(9). 531–531. 5 indexed citations
11.
Lee, Donghyuk, Hye‐Youn Kim, Ikhyun Jun, et al.. (2021). Plasma Membrane Localized GCaMP-MS4A12 by Orai1 Co-Expression Shows Thapsigargin- and Ca2+-Dependent Fluorescence Increases. Molecules and Cells. 44(4). 223–232. 1 indexed citations
12.
Park, Ji Soo, Beodeul Kang, Yehyun Park, et al.. (2019). Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors. Journal of Cancer Prevention. 24(1). 48–53. 2 indexed citations
13.
Ahn, Soojung, et al.. (2019). Oxaliplatin-induced Peripheral Neuropathy, Symptoms, Distress and Quality of Life among Korean Patients with Gastrointestinal Cancer. Asian Oncology Nursing. 19(4). 204–204. 1 indexed citations
14.
15.
Park, Ji Soo, Seung‐Hoon Beom, Hyo Song Kim, et al.. (2017). The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status. Gastric Cancer. 21(2). 213–224. 28 indexed citations
16.
Jeon, Justin Y., et al.. (2016). A phenomenological Study on Exercise Perception for Colorectal Cancer Patients undergoing Adjuvant Chemotherapy. The Korean Journal of Physical Education. 55(1). 687–700. 2 indexed citations
17.
Park, Ji Soo, Sun Young Rha, Hyun Cheol Chung, et al.. (2014). Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer. Oncology. 88(3). 147–156. 14 indexed citations
18.
Zhang, Xianglan, Ji Soo Park, Minkyu Jung, et al.. (2014). PTEN Deficiency as a Predictive Biomarker of Resistance to HER2-Targeted Therapy in Advanced Gastric Cancer. Oncology. 88(2). 76–85. 32 indexed citations
19.
Jung, Minkyu, et al.. (2012). Body fluid MMP-2 as a putative biomarker in metastatic breast cancer. Oncology Letters. 3(3). 699–703. 10 indexed citations
20.
Jeon, Seong Woo, Seok‐Jin Yoon, Soo Young Park, et al.. (2008). Microscopic colitis in a single center study: clinical feature & characteristics. The Korean Journal of Internal Medicine. 74(4). 397–402. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026